Models using comprehensive, lesion-level, longitudinal [ 68 Ga]Ga-DOTA-TATE PET-derived features lead to superior outcome prediction in neuroendocrine tumor patients treated with [ 177 Lu]Lu-DOTA-TATE.
Victor Santoro-FernandesBrayden SchottAli DeatschQuinton KeigleyThomas FranckenRenuka IyerChristos FountzilasScott PerlmanRobert JerajPublished in: European journal of nuclear medicine and molecular imaging (2024)
Neuroendocrine tumor, peptide receptor radionuclide therapy, Somatostatin Receptor Imaging, Outcome Prediction, Treatment Response Assessment.